e.g. Tata motors, Reliance MF, 500570

Tata India Pharma & HealthCare Fund - Growth

Equity Pharma Very High

NAV on (17 Aug 2026 )

₹33.54

(-0.27%)

Fund Size

₹1541.42 Crores

1Y Returns

8.07 %

 
Earn 1% Higher Returns in Direct Funds on dhan Invest  Top Funds
Disclaimer: Mutual Fund investments are subject to market risks. Read all scheme related documents carefully before investing.

 

Investment Objective

The investment objective of the scheme is to seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

AMC

Tata Asset Management Ltd.

Fund Details

Launch Date

December 4, 2015

Fund Manager

Mr. Rajat Srivastava

Initial Price

10

AUM Fund

1541.42 Cr

Min investment

Rs 5000

Expense Ratio

2.28%

SIP Minimum Investment

Daily - Rs. 150/- and in multiples of Re. 1/- thereafter. Minimum 12 installments.Monthly - Rs. 150/- and multiple of Re. 1/- thereafter. Minimum 12 installments.Monthly - Rs. 1000/- and multiple of Re. 1/- thereafter. Minimum 6 installments.Quarterly - Rs. 1000/- and multiple of Re. 1/- thereafter. Minimum 6 installments.Quarterly - Rs. 1500/- and multiple of Re. 1/- thereafter. Minimum 4 installments.

Exit Load

0.25% of NAV if redeemed/switched out before 30 days from the date of allotment.

1 Month

+1.55%

6 Months

+12.64%

1 Year

+8.07%

2 Years (CAGR)

+6.30%

3 Years (CAGR)

+18.36%

5 Years (CAGR)

+13.39%

Equity / Mid Cap funds 1Y 3Y Fund Size (Cr)
25.30% 0.00% ₹2939.98
25.30% 0.00% ₹2939.98
24.47% 0.00% ₹682.39
24.47% 0.00% ₹682.39
24.01% 0.00% ₹111.64
Address
1903, B-Wing, Parinee Crescenzo,G-Block, Bandra Kurla Complex, Bandra East, Mumbai Maharashtra India 400051
Phone
+91 22 66578282
Fax
+91 22 22613782
Launch Date
December 4, 2015
Custodian
Deutsche Bank; HDFC Bank; Standard Chartered Bank; ICICI Bank; Orbis Financial Corporation Ltd
Registrar & Transfer Agent
CAMS Ltd.

Frequently Asked Questions

Q: What is the current NAV of Tata India Pharma & HealthCare Fund - Growth?

A: The latest NAV of Tata India Pharma & HealthCare Fund - Growth is ₹ 33.54 as on 17 Aug 2026.

Q: What type of mutual fund is Tata India Pharma & HealthCare Fund - Growth?

A: Tata India Pharma & HealthCare Fund - Growth is a 'Equity - Pharma' type mutual fund managed by 'Tata Asset Management Ltd.'.

Q: What is the expense ratio of Tata India Pharma & HealthCare Fund - Growth?

A: The expense ratio of Tata India Pharma & HealthCare Fund - Growth is 2.28%, which impacts overall returns.

Q: Who manages Tata India Pharma & HealthCare Fund - Growth?

A: Tata India Pharma & HealthCare Fund - Growth is managed by Mr. Rajat Srivastava, who oversees investment strategy and portfolio decisions.

Q: Is Tata India Pharma & HealthCare Fund - Growth a good investment?

A: Tata India Pharma & HealthCare Fund - Growth may be suitable depending on your financial goals, risk appetite, and investment horizon. Always evaluate fund performance and consult a financial advisor.

Q: What is the exit load of Tata India Pharma & HealthCare Fund - Growth?

A: The exit load of Tata India Pharma & HealthCare Fund - Growth is 0.25% of NAV if redeemed/switched out before 30 days from the date of allotment., applicable if redeemed within the specified period.

Q: How is Tata India Pharma & HealthCare Fund - Growth taxed?

A: Taxation depends on the fund type (equity/debt) and holding period as per Indian tax laws.

Close

Add Tata India Pharma & HealthCare Fund to your Watchlist

Alert me if price...
Close

Add Tata India Pharma & HealthCare Fund to your Portfolio

:  
   
:    
 

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback